Pnc Financial Services Group, Inc. Phathom Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,347 shares of PHAT stock, worth $18,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,347
Previous 310
334.52%
Holding current value
$18,265
Previous $1,000
1100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PHAT
# of Institutions
137Shares Held
60.5MCall Options Held
1.35MPut Options Held
1.19M-
Frazier Life Sciences Management, L.P. Menlo Park, CA12.5MShares$169 Million6.31% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$101 Million20.28% of portfolio
-
Invesco Ltd. Atlanta, GA4.14MShares$56.1 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$47.4 Million41.56% of portfolio
-
Black Rock Inc. New York, NY2.93MShares$39.7 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $531M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...